New catalog for centralized purchasing platform for health products in Spain

20

Mar 2019

The new “Catalog of Goods and Services” for the centralized purchasing platform was presented to the regional health authorities by the Minister of Health on February 19, 2019. This new catalog includes up to 25,000 items, including drugs and medical aids and devices.

The Centralized Purchasing platform is based on two fundamental pillars:

  • The web platform of information and collaboration between the agents involved: a web page in which, transparently, anonymously and openly, all the information related to the centralized purchasing initiative for the National Health System can be accessed
  • The Catalog of Goods and Services of centralized purchasing: it is integrated into the Platform and includes nearly 25,000 articles (both drugs and health products) cataloged in a structured and hierarchical manner. The structure of the catalog allows the future incorporation of health services

The Centralized Purchasing initiative of the Spanish NHS started with the agreements of the NHS Interterritorial Council (CISNS) Plenary of March 18, 2010, which agreed on the establishment of an aggregate purchasing procedure for the Spanish NHS. Recently, the CISNS itself agreed to promote the centralized purchase of drugs, health products, and services, as a measure of rationalization, cohesion, and efficiency in the SNS.

Since 2013, 15 tenders have been made for more than 2,700 million euros, having generated savings of approximately 237 million euros. Non-patent drugs, patent-subject medicines and medical devices (gloves, gauze, bandages, glucose test strips, intraocular implants, hip and shoulder prostheses) have been on these tenders.

In the coming months, though this initiative, the centralized purchases of defibrillators and pacemakers will start, together with pharmaceuticals.

In the tenders carried out to date, 13 Autonomous Communities have participated.

See the Press release from the Spanish Minister of Health in Spanish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information

The latest related news

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

04

Mar 2022

On February 14, 2022, the Danish Treatment Council (Behandlingsråd), a new body for assessing treatments and health technologies that became fully operational in late May 2021, has announced its symposium, which will take place in Aalborg on May 11, 2022.

Read more

24

Feb 2022

On January 18, 2022, the Ministry of Health has awarded the Framework Agreement for the acquisition of 81 linear accelerators included in the High-End Technology Equipment Investment Plan. Furthermore, the National Institute of Health Management (INGESA) has also initiated the processing of the Framework Agreement that will facilitate the acquisition of the equipment in the fields of interventional cardiology, interventional vascular radiology, interventional neurovascular, digital brachytherapy, computed tomography, magnetic resonance imaging, PET-CT, SPECT-CT.

Read more

15

Feb 2022

In January 2022, the Basque Office for Health Technology Assessment (OSTEBA) released an HTA report aiming to assess and compare the efficacy, effectiveness, and safety of the mechanical circulatory support devices most used in the healthcare setting for the treatment and prevention of cardiogenic shock, including Impella® devices, intra-aortic balloon pumps, and extracorporeal membrane oxygenation.

Read more